The Stanford 25 Bedside Medicine Symposium, September 29-30, is a chance to dedicate two days to improving your bedside medicine skills and your ability to teach others the physical exam. Visit http://stanford.io/2vo8BAY for an overview and registration link.

A recent publication by Stanford's Joshua Knowles in The Journal of the American Medical Association (JAMA) has created buzz about the way he and his colleagues trace familial hypercholesterolemia (FH) through families. The cardiovascular disease is genetic, and an estimated 90% of U.S. patients with FH are unaware they have it. http://stanford.io/2uGDHUp

@Medscape Cardiology features a thought-provoking interview between Stanford Department of Medicine’s Bob Harrington and Aaron Kesselheim of Harvard Medical School and the Department of Medicine at Brigham and Women’s Hospital. During they discussion, Drs. Harrington and Kesselheim touch on prescription drug pricing in the US, innovative policies for reducing prices and more. http://wb.md/2uQhYt9

Medications can provide symptomatic improvement in some patients with chronic fatigue syndrome, says Stanford's Jose Montoya, "but no single pathogenic agent that can be fingered as the ultimate ME/CFS trigger has yet been isolated." With a recent study, however, Montoya believes he may be getting closer to pinning down genetic predispositions in the disease.

The misleading packaging of one cigarette brand increased sales over 400% since 2002, despite overall decline in tobacco use nationwide. Here's a look at the brand's claims and how they inspired Stanford Department of Medicine's Jodi Prochaska to start the new Tobacco Labeling Assessment project.

280 million people around the globe are living with a rare genetic disease. Fortunately, stem cell and gene therapies hold promise in treating these conditions. The new Stanford Center for Definitive and Curative Medicine will turn discoveries into stem cell and gene therapies to aid people who live with genetic diseases. http://stan.md/2uxcNRb

Stanford's Center for Clinical Research (SCCR) turned to the Community Advisory Board (CAB) for Clinical Research for guidance on recruiting 10,000 subjects for an online study registry. The challenge was not only the study's large scale but also its focus on gathering information instead of offering treatment. Even still, CAB knew just what to do.

Based on the promise of new treatments, Stanford has launched a new Center for Cancer Cell Therapy with a $10 million gift from Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke. http://stan.md/2toaf4T

This year’s Medicine X conference will focus on the theme of “Citizenship” as it explores topics related to digital health, challenges and opportunities in medicine, ePatients, research, business, design and more in around 200 breakout sessions and main stage talks.

Register: http://bit.ly/2uCHHHQ
Learn more: http://stan.md/2uCTo19